Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.

Diabetes care - 1 Oct 2022

Maran Alberto, Morieri Mario Luca, Falaguasta Daniele, Avogaro Angelo, Fadini Gian Paolo

Abstract excerpt

OBJECTIVE: Existence of a fast-glycator phenotype among people with type 1 diabetes (T1D) is debated. Routine use of glucose sensors allows the comparison of long-term average glucose levels with laboratory HbA1c values. We herein evaluated whether participants with T1D and HbA1c values higher than their glucose management indicator (GMI) had greater accumulation of advanced glycation end products (AGEs) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Diabetes Mellitus, Type 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycated Hemoglobin

Share to Glycation End Products, Advanced

Share to Phenotype

Source

Identifiers

PMID: 35972256
DOI: 10.2337/dc22-0980

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.PMID 35972256Read ↗

Association between the GMI/HbA1c ratio and preclinical carotid atherosclerosis in type 1 diabetes: impact of the fast-glycator phenotype across age groups.Semantic proximity Read ↗

Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Semantic proximity Read ↗

Heterogeneity of glycaemic phenotypes in type 1 diabetes.Semantic proximity Read ↗

New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.Semantic proximity Read ↗

Association of accelerated phenotypic aging, genetic risk, and lifestyle with progression of type 2 diabetes: a prospective study using multi-state modelSemantic proximity Read ↗

Continuous glucose monitor–derived glucotypes and cardiovascular risk scores in individuals without diabetesSemantic proximity Read ↗

Targeted proteomics of extreme vascular phenotypes in type 1 diabetes: the ESCAPER study.Semantic proximity Read ↗

A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general populationSemantic proximity Read ↗

Longitudinal study reveals plasma glycans associations with prediabetes/type 2 diabetes in KORA studySemantic proximity Read ↗

Association between glycemia risk index and diabetic retinopathy in patients with type 2 diabetes mellitus: A cross-sectional studySemantic proximity Read ↗

Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.Semantic proximity Read ↗

Continuous Glucose Monitoring Reveals Glycemic Patterns Associated with End-Organ Alterations in Early DysglycemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.